Acute Renal Failure

ARF Can Be First Sign of Myeloma

Caroline Helwick February 05, 2010

NEW ORLEANS—Acute renal failure (ARF) induced by pathogenic light chains can be the first presenting sign of multiple myeloma, and prompt treatment of the malignancy is critical to reversing renal damage, according to a study presented by European investigators at the American Society of Hematology 51st annual meeting.
 

Donor ARF Need Not Stop Renal Transplants

Jill Stein October 08, 2009

Acute renal damage may resolve in the absence of the underlying cause.
 

Women Fare Better After Severe Trauma

Rosemary Frei, MSc September 11, 2009

They are less likely than men to suffer acute renal failure and other complications, researchers say.
 

A Downside to Angiotensin Blockade?

Delicia Honen Yard June 18, 2009

Researcher Macaulay Onuigbo, MD, MSc, proposes that ACE inhibitors and angiotensin receptor blockers can cause renal failure.
 

Study: ARF Risk Greater with CABG

Caroline Helwick June 15, 2009

ORLANDO—Acute renal failure (ARF) may be more likely to develop following coronary artery bypass grafting (CABG) than percutaneous coronary intervention (PCI), according to researchers.
 

FDA Takes Action on Some Bowel Preps

Rosemary Frei, MSc February 04, 2009

THE FDA is recommending that only prescription oral sodium phosphate (OSP) bowel preparations be used by patients for bowel cleansing prior to undergoing colonoscopy. The agency also is requiring "black box" warnings on these products.
 

Obesity in CKD: Is It Friend or Foe?

Csaba P. Kovesdy, MD, FASN February 03, 2009

In a seemingly paradoxical manner, observational studies examining outcomes in patients suffering from CKD have found significantly altered risk-factor patterns such that conventional mortality risk factors have been associated with better survival; this phenomenon was termed "reverse epidemiology" or "risk factor paradox."
 

New Anemia Drug Safe

Jody A. Charnow December 10, 2008

Ferumoxytol, a novel, semi-synthetic, superparamagnetic iron oxide nanoparticle administered by injection, is well tolerated and has a safety profile similar to placebo in CKD patients with anemia, according to a report in the American Journal of Kidney Diseases.
 

IV Calcitriol May Prevent Parathyroid Gland Growth

Jody A. Charnow December 10, 2008

IV CALCITRIOL treatment in patients with early-stage secondary hyperparathyroidism prevents parathyroid (PT) gland growth, researchers report.
 

New Approach May Predict IUI Success

John Schieszer December 08, 2008

SAN FRANCISCO—Multiplying total motile sperm count by the percent of normal sperm determined by strict morphology (TM×SM) may be a significant predictor of pregnancy when sperm morphology is less than 5%, according to a new study by Texas researchers.
 

NKF Live

Sign up for the NKF Live e-newsletter to receive daily news coverage of the National Kidney Foundation 2010 Spring Clinical Meetings in Orlando, Fla.

Click here to sign up today



Visit Fresenius Medical Care during the National Kidney Foundation 2010 Spring Clinical Meetings in Orlando, Fla. at Booth #407.
Take a look back at our thorough coverage from Renal Week 2009 featuring daily articles in four subject areas.
Articles | Video | Photos

Renal Nutrition Update

For the latest nutrition news and studies, click here to visit our Renal Nutrition Update dept.

Job Search


Hyperphosphatemia in CKD
This article by Wajeh Y. Qunibi, MD, FACP of the University of Texas Health Sciences Center at San Antonio is the final in a series on managing hyperphosphatemia in CKD patients.
Part V: Neenoo Khosla, MD, and Stuart M. Sprague, DO
Part IV: Michal L. Melamed, MD, MHS
Part III: Kamyar Kalantar-Zadeh, MD, PhD, MPH
Part II: Joseph A. Coladonato, MD, MHS
Part I: Csaba P. Kovesdy, MD
Stay up to date on the latest Renal and Urology meetings with our calendar. Check it out.

Our World Literature Review department has information on the latest nephrology and urology studies from around the world.